Bicycle Therapeutics (BCYC) Gains from Sales and Divestitures (2019 - 2023)
Bicycle Therapeutics (BCYC) reported Gains from Sales and Divestitures of $119144.0 for Q4 2023, up 240.41% on a YoY basis from $35000.0 in Q4 2022, and up 19.58% quarter-over-quarter from $99638.0 in Q3 2023.
Bicycle Therapeutics (BCYC) Gains from Sales and Divestitures (2019 - 2023) Analysis & Trends
Bicycle Therapeutics has reported Gains from Sales and Divestitures for 3 years, with the latest figure at $119144.0 in Q4 2023.
- For the quarter ending Q4 2023, Gains from Sales and Divestitures rose 240.41% year-over-year to $119144.0; the trailing twelve-month figure through Dec 2023 stood at $119144.0 (up 240.41% YoY), and the FY2023 full-year result was $119144.0, up 240.41% from the prior year.
- Gains from Sales and Divestitures for Q4 2023 stood at $119144.0, up from $99638.0 in the prior quarter.
- The five-year high for Gains from Sales and Divestitures was $119144.0 in Q4 2023, with the low at $35000.0 in Q1 2022.
- Historically, Gains from Sales and Divestitures has averaged $67853.8 across 3 years, with a median of $78781.0 in 2023.
- The largest YoY upside for Gains from Sales and Divestitures was 240.41% in 2023 against a maximum downside of 62.82% in 2023.
- Bicycle Therapeutics' Gains from Sales and Divestitures stood at $83947.0 in 2019, then slumped by 58.31% to $35000.0 in 2022, then jumped by 240.41% to $119144.0 in 2023.
- The last three Gains from Sales and Divestitures figures came in at $119144.0 (Q4 2023), $99638.0 (Q3 2023), and $78781.0 (Q2 2023), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Bicycle Therapeutics | 278.04 Mn | 278.04 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 119,144.00 |
| Dec 31, 2023 | 119,144.00 |
| Sep 30, 2023 | 99,638.00 |
| Sep 30, 2023 | 99,638.00 |
| Jun 30, 2023 | 78,781.00 |
| Jun 30, 2023 | 78,781.00 |
| Mar 31, 2023 | 56,988.00 |
| Mar 31, 2023 | 56,988.00 |
| Dec 31, 2022 | 35,000.00 |
| Dec 31, 2022 | 35,000.00 |
| Sep 30, 2022 | 35,000.00 |
| Sep 30, 2022 | 35,000.00 |
| Jun 30, 2022 | 35,000.00 |
| Jun 30, 2022 | 35,000.00 |
| Mar 31, 2022 | 35,000.00 |
| Mar 31, 2022 | 35,000.00 |
| Dec 31, 2019 | 83,947.00 |
| Dec 31, 2019 | 83,947.00 |
| Sep 30, 2019 | 83,947.00 |
| Sep 30, 2019 | 83,947.00 |